\n
\n "Effect of Alteplase vs No alteplase on mRS 0-2 at 90 days in Stroke 3-4.5 hours prior" is a comparative effect estimate.\n
\n
"
];
fhir:Evidence.url [ fhir:value "http://hl7.org/fhir/Evidence/example-stroke-3-4half-alteplase-vs-no-alteplase-mRS0-2"];
fhir:Evidence.title [ fhir:value "Effect of Alteplase vs No alteplase on mRS 0-2 at 90 days in Stroke 3-4.5 hours prior"];
fhir:Evidence.status [ fhir:value "draft"];
fhir:Evidence.useContext [
fhir:index 0;
fhir:UsageContext.code [
fhir:Coding.system [ fhir:value "http://terminology.hl7.org/CodeSystem/usage-context-type" ];
fhir:Coding.code [ fhir:value "focus" ]
];
fhir:UsageContext.valueCodeableConcept [
fhir:CodeableConcept.text [ fhir:value "Stroke" ]
]
];
fhir:Evidence.relatedArtifact [
fhir:index 0;
fhir:RelatedArtifact.type [ fhir:value "citation" ];
fhir:RelatedArtifact.label [ fhir:value "Lees 2016" ];
fhir:RelatedArtifact.display [ fhir:value "Figure 2 Lees 2016" ];
fhir:RelatedArtifact.citation [ fhir:value "Lees KR, Emberson J, Blackwell L, Bluhmki E, Davis SM, Donnan GA, et al; Stroke Thrombolysis Trialists’ Collaborators Group. Effects of alteplase for acute stroke on the distribution of functional outcomes: a pooled analysis of 9 trials. Stroke. 2016;47:2373-2379. PMID 27507856" ];
fhir:RelatedArtifact.url [ fhir:value "https://doi.org/10.1161/STROKEAHA.116.013644" ]
];
fhir:Evidence.description [ fhir:value "mRS 0-2 at 90 days Odds Ratio 1.2 for Alteplase vs. No Alteplase in patients with acute ischemic stroke 3-4.5 hours prior"];
fhir:Evidence.variableDefinition [
fhir:index 0;
fhir:Evidence.variableDefinition.variableRole [
fhir:CodeableConcept.coding [
fhir:index 0;
fhir:Coding.system [ fhir:value "http://terminology.hl7.org/CodeSystem/variable-role" ];
fhir:Coding.code [ fhir:value "population" ];
fhir:Coding.display [ fhir:value "population" ]
]
];
fhir:Evidence.variableDefinition.observed [
fhir:link